American Society for Experimental Neurotherapeutics

What American Society for Experimental Neurotherapeutics does

The American Society for Experimental Neurotherapeutics (ASENT) is a 501(c)(3) nonprofit professional society founded in 1997 and headquartered in Haddonfield, New Jersey. It serves a multi-stakeholder community in the neurotherapeutics field, including academic researchers, clinical neurologists, industry scientists, government regulators, and patient advocates, by convening them around peer-reviewed science, education, and clinical translation. Its core products and platforms include an annual meeting (with a 2026 edition announced), a Clinical Trials Course, the peer-reviewed Neurotherapeutics Journal published in partnership with Elsevier, a Career Center connecting employers with neurotherapeutics specialists, and a tiered individual membership program.

ASENT's business model is that of a traditional membership-based professional society. Revenue is generated from individual membership dues priced in tiers (ranging roughly $50 to $250 per year), event registration fees (approximately $350 to $950 per attendee), abstract submission fees, Career Center job postings (starting around $299), and corporate sponsorships and donations. Go-to-market is community-driven: content and programming are promoted to existing members and the broader neurotherapeutics field via the website, email, and partner channels such as Elsevier. Leadership as of April 2025 includes President Ludy C. Shih, MD, Executive Director Jessica Smith, and Journal Editor-in-Chief M. Maral Mouradian, MD. The society has operated for 28+ years with no disclosed AI/ML capabilities and no external funding rounds.

Name

American Society for Experimental Neurotherapeutics

Legal name

American Society for Experimental Neurotherapeutics

Website

https://asent.org

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

1–10 employees

Short description

The American Society for Experimental Neurotherapeutics (ASENT) is a 501(c)(3) nonprofit professional society, founded in 1997 and based in Haddonfield, NJ, that convenes academic, clinical, industry, government, and advocacy stakeholders in neurotherapeutics via an annual meeting, a Clinical Trials Course, the peer-reviewed Neurotherapeutics Journal (Elsevier), a Career Center, and tiered individual membership.

Ownership category

akta.pro rank

Headquarters

HQ city

Haddonfield

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Dues: ASENT generates revenue through annual membership fees from multiple categories including AAN Members ($170/year), Academic members ($200/year), Advocacy members ($125/year), Government members ($50/year), and Industry/Private/For-Profit members ($250/year). Membership provides access to the annual meeting, journal access, career center, and networking opportunities.
2. Event Registration Fees: Revenue from annual meeting registrations with various tiers including early bird member rates ($400), standard non-member rates ($750 general, $950 industry), and trainee rates ($450). The Clinical Trials Course generates additional registration fees ($350 for course only, $150 add-on to annual meeting).
3. Abstract Submission Fees: Fees for submitting abstracts to the annual meeting: $75 for members, $175 for non-members, with free options for trainees.
4. Career Center Job Postings: Revenue from employers posting jobs on the ASENT Career Center, with prices starting at $299 for a 60-day posting.
5. Corporate Sponsorships and Donations: Support from pharmaceutical and biotech companies through event sponsorships (annual meeting and clinical trials course), and individual donations at prescribed levels ($500, $1000, $2500) or custom amounts.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

ASENT is a 501(c)(3) professional society that delivers membership programs, an annual scientific meeting, a two-day clinical trials course, the peer-reviewed Neurotherapeutics journal, and a specialized career center for the neurotherapeutics field. It convenes stakeholders from academia, industry, government, and patient advocacy to advance therapies for nervous system disorders.

Product overview

ASENT operates as a platform offering multiple interconnected services for the neurotherapeutics field. The core portfolio includes the Annual Meeting as the premier annual conference for neurotherapeutics professionals, the Neurotherapeutic Clinical Trials Course as a specialized training program, the Neurotherapeutics Journal as the official peer-reviewed publication, the Career Center as a specialized job board, and membership programs providing access to all these services with tiered pricing based on member type (academic, industry, government, advocacy, trainee).

Differentiator

Problem solved

Functional benefit

Brands

• Neurotherapeutics Journal: Official journal of ASENT, published by Elsevier. Led by Editor-In-Chief M. Maral Mouradian, MD, Rutgers Robert Wood Johnson Medical School.

Products and services

• ASENT Annual Meeting The premier annual scientific conference for neurotherapeutics professionals, bringing together senior leaders from healthcare payers, providers, employers, investors, startups, pharma, policymakers, funders, and innovation centers to improve the process of bringing neurotherapeutics to market. Includes scientific symposia, industry roundtables, CNS pipeline presentations, poster sessions, and sponsored symposia.
• Neurotherapeutic Clinical Trials Course A two-day intensive training course covering the full arc of neurotherapeutics clinical trial design and implementation, from preclinical programs through Phase III. Includes didactic sessions, interactive workshops, panel discussions, and networking with industry leaders, addressing the unique challenges of developing treatments for nervous system disorders.
• Neurotherapeutics Journal The official peer-reviewed journal of ASENT, published by Elsevier under Editor-in-Chief M. Maral Mouradian, MD. Provides critical reviews of important topics relating to treatment of neurological disorders and publishes original research articles in translational neuroscience. ASENT members receive complimentary access and discounted article processing charges.
• ASENT Career Center A specialized online job board for the neurotherapeutics field where employers post positions and job seekers find roles across industry, academia, government, and advocacy. Postings range from chief scientific officer to research scientist to department chair, and the platform maximizes distribution via partner job aggregator websites.
• ASENT Membership Tiered annual professional membership program with categories for AAN members, Academic, Advocacy, General, Government, Industry/For-Profit, JSNT members, LMIC attendees, Retired professionals, and Trainees. Benefits include access to the annual meeting, complimentary Neurotherapeutics journal access, clinical trials course discounts, career center access, and ASENT communications.

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• ElseviercoreStrategic or Co-development PartnerElsevier serves as the publisher for Neurotherapeutics, the official journal of ASENT. The journal is led by Editor-In-Chief M. Maral Mouradian, MD and provides a multidisciplinary perspective on translational neuroscience. All ASENT members receive complimentary access to the journal and discounted article processing charges (APC) for submitting research.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Alzheimer's Association: A large US patient-advocacy and research-focused non-profit that runs a major international conference (AAIC), funds research, and convenes industry-government-academia stakeholders in Alzheimer's therapeutics. It is one of the largest competing draws on neurotherapeutics industry sponsorships and advocacy-group engagement that ASENT also targets.
• Society for Neuroscience: The largest global neuroscience professional society with a massive annual meeting, multiple journals (including a partnership with Elsevier), and a broad member base spanning basic and clinical neuroscience. It competes with ASENT for neuroscience researcher attendance and CNS-related industry sponsorship, though at a much larger and broader scale.
• American Academy of Neurology: The largest US neurology professional society, serving the full neurology community with annual meetings, journals (Neurology), CME, and advocacy. ASENT explicitly cross-lists AAN members in its membership tiers, reflecting their overlap in audience and the broader society's gravitational pull on ASENT's potential members and sponsors.
• American College of Neuropsychopharmacology: A prestigious US professional society focused on neuropsychopharmacology with annual meetings, publications (Neuropsychopharmacology), and a strong academic-industry interface. It competes with ASENT for CNS drug-development industry sponsorship and for academic researchers working at the intersection of neuropharmacology and therapeutics.

Regional players

• Child Neurology Society: A US-based professional society for child neurologists with an annual meeting, peer-reviewed journal, and member tiers. It overlaps with ASENT in the academic-clinician segment and competes for pediatric neurotherapeutics sponsorships, though its therapeutic scope is narrower (pediatric only).
• Peripheral Nerve Society: A small international professional society for peripheral nerve specialists with an annual meeting and journal. It mirrors ASENT's structure (small-membership non-profit society, annual meeting, peer-reviewed journal) and competes for similar sized sponsorships in the neurotherapeutics space, though in a narrower subspecialty.

Emerging players

• Cure SMA: A US patient-advocacy non-profit for spinal muscular atrophy that runs an annual conference, research-funding programs, and industry partnerships in neurotherapeutics. It is comparable as a neurotherapeutics stakeholder organization (combining advocacy, research, and industry convening) and overlaps with ASENT in the advocacy segment of ASENT's four-stakeholder model.
• Movement Disorder Society: An international professional society serving clinicians and researchers in movement disorders, including Parkinson's disease and essential tremor — both areas of ASENT's incoming president Ludy Shih's research focus. It competes for the same industry sponsors (CNS pipeline companies) and offers overlapping annual meeting content for a neurotherapeutics-adjacent subspecialty.

Direct peers

• International Society for CNS Clinical Trials and Methodology: A non-profit organization focused specifically on methodology and design of CNS clinical trials — overlapping directly with ASENT's Clinical Trials Course and annual meeting content. It targets the same industry, academic, and regulatory audience ASENT serves, particularly biostatisticians, clinical pharmacologists, and trial designers in neurotherapeutics.
• American Neurological Association: A 501(c)(3) academic neurology professional society that convenes annual meetings, publishes a peer-reviewed journal, and serves neurologists across subspecialties. It directly competes with ASENT for academic neurologist mindshare, journal authors, and institutional memberships in the neurotherapeutics-adjacent space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ASENT_Org
• Facebookfacebook.com/ASENTorg

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about American Society for Experimental Neurotherapeutics